# Aerovate Therapeutics (stock symbol: AVTE) Logo in transparent PNG format

## Aerovate Therapeutics Logo large

### Aerovate Therapeutics Logo large Download PNG (58.57 KB)

![Aerovate Therapeutics Logo large Download PNG (58.57 KB)](/img/orig/AVTE_BIG-644edc6b.png)

## Aerovate Therapeutics Logo icon format

### Aerovate Therapeutics Logo icon format Download PNG (18.87 KB)

![Aerovate Therapeutics Logo icon format Download PNG (18.87 KB)](/img/orig/AVTE-b0270cbe.png)

## Aerovate Therapeutics Logo large for dark backgrounds

### Aerovate Therapeutics Logo large for dark backgrounds Download PNG (28.42 KB)

![Aerovate Therapeutics Logo large for dark backgrounds Download PNG (28.42 KB)](/img/orig/AVTE_BIG.D-c045d714.png)

## Aerovate Therapeutics Logo icon format for dark backgrounds

### Aerovate Therapeutics Logo icon format for dark backgrounds Download PNG (8.17 KB)

![Aerovate Therapeutics Logo icon format for dark backgrounds Download PNG (8.17 KB)](/img/orig/AVTE.D-fcedd223.png)

## About Aerovate Therapeutics

Aerovate Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of drugs that enhance the lives of patients with rare cardiopulmonary diseases in the United States. The company focuses on advancing AV-101, a dry powder inhaled formulation of imatinib for the treatment of pulmonary arterial hypertension, which is in Phase 2b/Phase 3 trial. Aerovate Therapeutics, Inc. was incorporated in 2018 and is headquartered in Waltham, Massachusetts.

1. Website domain: aerovatetx.com
2. Employees: 25
3. Marketcap: $0.52 Billion USD


## Categories
- [x] ðŸ‡ºðŸ‡¸ United States
- [x] ðŸ’Š Pharmaceuticals
- [x] ðŸ§¬ Biotech
